Prestigious Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry
LOS ANGELES, Nov. 3, 2022 /PRNewswire-PRWeb/ -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe, today announced the results of the second annual BioTech Breakthrough Awards program. The winning BioTech Breakthrough selections for 2022 showcase life sciences and biotechnology companies that push ingenuity and exemplify the best in biotech solutions across the globe.
The mission of the annual BioTech Breakthrough Awards program is to conduct the industry's most comprehensive analysis and evaluation of the top companies, solutions and products in the life sciences and biotechnology industry today. This year's program attracted more than 1,350 nominations from over 12 different countries throughout the world. Categories include: BioPharma, Genomics, Therapeutics, Food Science, Immunology, BioServices and more.
"Advances in biological sciences, combined with accelerating development of computing, data processing, and AI are fueling a new wave of innovation in the healthcare sector. These advances are providing new understanding, new materials, new tools, as well as lower costs. We're seeing trends in use of next-generation computing technology, growth in personalized treatment of rare diseases, vaccine development and the advancement of cell and gene therapies, to name a few," said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. "It's an exciting time in the industry and we are thrilled to highlight the 'breakthrough' biotechnology solutions, services and companies around the world for our 2022 program. We extend our sincerest congratulations to our 2022 BioTech Breakthrough Award winners."
The 2022 BioTech Breakthrough Awards program winners include:
BioPharma
Vaccine Innovation of the Year: Fast Track Automation, Honeywell
Overall BioPharma Solution of the Year: Scientist.com
Overall BioPharma Company of the Year: Boundless Bio
Genomics
Overall Genomics Innovation of the Year: Colossal Biosciences
Therapeutics
Therapeutics Solution of the Year: PharmaEssentia
Therapeutics Innovation of the Year: Cartography Biosciences
Diagnostics
Diagnostics Company of the Year: Longhorn
Immunology
Cancer Immunology Solution of the Year: Promontory Therapeutics
Overall Immunology Company of the Year: Ozette Technologies
Data & Analytics
Analytics Solution of the Year: Waters Corporation
Predictive Analytics Solution of the Year: VeriSIM Life
Analytics Solution Provider of the Year: Saama Technologies
Nutraceuticals
Nutraceutical Innovation of the Year: Brightseed
Medical Technology
Oncology Innovation of the Year: Imagene AI
MedTech Solution of the Year: Abbott
BioAgriculture
BioAg Breeding Solution of the Year: Dewey Scientific
Overall BioAgriculture Solution of the Year: C16 Biosciences
Overall BioAgriculture Company of the Year: Solis Agrosciences
BioInformatics
BioInformatics Company of the Year: Golden Helix
Industry Leadership
BioTech Company CEO of the Year: James Peyer, Ph.D., Cambrian Biopharma
BioTech Startup of the Year: Abata Therapeutics
BioTechnology Innovator of the Year: PTC Therapeutics
Overall BioTech Company of the Year: Vizgen
####
About BioTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughawards.com
Media Contact
Bryan Vaughn, BioTech Breakthrough Awards, 949.529.4120, Bryan@BioTechBreakthroughAwards.com
SOURCE BioTech Breakthrough Awards
Share this article